Posaconazole Tablet, Delayed Release
Product Images NDC 69238-1476

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 69238-1476). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Posaconazole Delayed Release Tablets 1)

Chemical structure of posaconazole, showing its molecular framework including fluorinated aromatic rings, triazole moieties, and various functional groups characteristic of this antifungal compound.*

FDA Label Image

30ct Label (Posaconazole Delayed Release Tablets 2)

Posaconazole 100 mg delayed-release tablets label from Amneal Pharmaceuticals NY LLC. The label states each tablet contains 100 mg posaconazole and indicates storage conditions. It also notes a warning about non-interchangeability with Noxafil oral suspension. The package contains 30 tablets and shows a barcode and distributor information from Amneal Pharmaceuticals LLC, Bridgewater, NJ.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.